Clinical Trials on Papillary Renal Cell Carcinoma Type 2 in Korea, Republic of
Total 609 results
-
Seoul National University HospitalTerminatedCarcinoma, Papillary, FollicularKorea, Republic of
-
National Cancer Institute (NCI)CompletedRecurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell CarcinomaUnited States
-
National Cancer Institute (NCI)Canadian Cancer Trials GroupActive, not recruitingUnresectable Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell Carcinoma | Metastatic Papillary Renal Cell Carcinoma | Locally Advanced Papillary Renal Cell CarcinomaUnited States, Canada
-
Korean Association of Endocrine SurgeonsCompletedPapillary Thyroid MicrocarcinomaKorea, Republic of
-
Seoul National University HospitalActive, not recruitingThyroid Cancer | Papillary Thyroid MicrocarcinomaKorea, Republic of
-
Seoul National University HospitalRecruitingThyroid Cancer | Papillary Thyroid MicrocarcinomaKorea, Republic of
-
Yonsei UniversityCompletedPapillary Thyroid CarcinomaKorea, Republic of
-
Yonsei UniversityCompletedPapillary Thyroid CarcinomaKorea, Republic of
-
Samsung Medical CenterCompletedLocally Advanced or Metastatic Non-clear Cell Type Renal Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalCompletedThe Efficacy and Safety of Prophylactic Central Lymph Node Dissection in Papillary Thyroid CarcinomaThyroid Cancer, PapillaryKorea, Republic of
-
Asan Medical CenterSamsung Medical Center; Seoul National University Hospital; Kyungpook National...UnknownMetastatic Renal Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalUnknownLocalized Renal Cell CarcinomaKorea, Republic of
-
Asan Medical CenterCompletedMetastatic Renal Cell CarcinomaKorea, Republic of
-
Asan Medical CenterIpsenNot yet recruitingRenal Cell CancerKorea, Republic of
-
Seoul National University HospitalPfizerCompletedRenal Cell Carcinoma | Nonclear Cell | Temsirolimus ResistanceKorea, Republic of
-
PfizerCompletedAdvanced Renal Cell CarcinomaKorea, Republic of
-
Yonsei UniversityRecruitingClear Renal Cell Cancer (< 7cm Size)Korea, Republic of
-
Seoul National University HospitalCompleted
-
Samsung Medical CenterUnknownRenal Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalTerminatedMetastatic Malignant Melanoma and Renal Cell CarcinomaKorea, Republic of
-
National Cancer Center, KoreaSeoul National University Hospital; Seoul National University Bundang Hospital and other collaboratorsNot yet recruitingPapillary Thyroid Carcinoma | Thyroid CancerKorea, Republic of
-
Yonsei UniversityRecruitingKidney Cancer | Synchronous Neoplasm | Clear Cell Renal Cell Carcinoma MetastaticKorea, Republic of
-
Seoul National University HospitalCompleted
-
Yonsei UniversityCompletedRenal Cell CarcinomaKorea, Republic of
-
Samsung Medical CenterCompletedRenal Cell Carcinoma | Hepatocellular CarcinomaKorea, Republic of
-
Seoul National University HospitalActive, not recruiting
-
LG Life SciencesCompletedType 2 DM Patients With Moderate or Severe Renal ImpairmentKorea, Republic of
-
Seoul National University HospitalCompletedCarcinoma, Renal Cell | ThrombusKorea, Republic of
-
Korean Urological Oncology SocietyPfizerUnknownClear Cell Renal Cell Carcinoma | MetastasisKorea, Republic of
-
Dong Jun LimUnknownThyroid Cancer, PapillaryKorea, Republic of
-
Yonsei UniversityRecruitingProstate Cancer | Bladder Cancer | Renal Cell Cancer | Ureter CancerKorea, Republic of
-
Yonsei UniversityRecruitingProstate Cancer | Bladder Cancer | Renal Cell Cancer | Ureter Cancer | Urological MalignanciesKorea, Republic of
-
Seoul National University HospitalUnknownCarcinoma, Renal Cell | Treatment Outcome | Pathology | Hemoglobin A1c Protein, HumanKorea, Republic of
-
Boehringer IngelheimWithdrawnAnal Canal Squamous Cell CarcinomaKorea, Republic of
-
SanofiCompleted
-
Seoul National University HospitalClinical Research Center for Solid Tumor, KoreaCompletedLocally Advanced Head and Neck Squamous Cell CarcinomaKorea, Republic of
-
Samyang Biopharmaceuticals CorporationUnknownHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalClinical Research Center for Solid Tumor, KoreaCompletedHead and Neck NeoplasmKorea, Republic of
-
Dong-A UniversityCompletedNodular Basal Cell CarcinomaKorea, Republic of
-
Yonsei UniversityActive, not recruitingHead and Neck Squamous Cell Carcinoma (HNSCC)Korea, Republic of
-
Samsung Medical CenterActive, not recruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalClinical Research Center for Solid Tumor, KoreaTerminatedHead and Neck Squamous Cell CarcinomaKorea, Republic of
-
Seoul National University HospitalUnknownHead and Neck Neoplasms | HNSCCKorea, Republic of
-
BayerCompletedCarcinoma, Renal Cell | Carcinoma, Renal Cell (Advanced)Poland, China, Slovakia, France, Germany, Indonesia, Korea, Republic of, Sweden, Philippines, Austria, Colombia, Czech Republic, Mexico, Russian Federation, Slovenia, Argentina, Greece, Netherlands
-
Yonsei UniversityUnknownRecurrent or Metastatic Squamous Cell Carcinoma of Head and NeckKorea, Republic of
-
Asan Medical CenterCompletedUrothelial CarcinomaKorea, Republic of
-
Sung Yong OhUnknownMetastatic Cancer | Esophagus Squamous Cell Carcinoma (SCC)Korea, Republic of
-
Samsung Medical CenterCompletedRenal Insufficiency | Albuminuria | Type2 Diabetes MellitusKorea, Republic of
-
Samsung Medical CenterActive, not recruitingUrothelial CarcinomaKorea, Republic of
-
Yonsei UniversityRecruitingHead and Neck Squamous Cell CarcinomaKorea, Republic of